Medincell announces shareholder meeting

• Medincell will hold a combined ordinary and extraordinary shareholder meeting in Jacou on Sept. 30, 2026.
• Shareholders will vote on the FY2026 standalone and consolidated accounts, profit allocation, and the use of share premium to absorb losses.
• Board items include related-party agreements, a director change with Elisabeth Svanberg proposed, and votes on executive pay plus a EUR 510,000 board fee pool.
• Capital measures include a share buyback authorization capped at 10% of share capital, with a maximum purchase price of EUR 40 per share and a EUR 50 million cap.
• Extraordinary resolutions cover potential cancellation of treasury shares, multiple capital-raising mandates, employee equity plans, and changes to employee-shareholder board representation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medincell SA published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.